Refresher Courses: Collaborative Learning - Jointly organised by the ECR Scientific Subcommittees Cardiac and Hybrid, Molecular and Translational Imaging
RC 600b - Cardiac amyloidosis imaging
Lectures
1
Chairpersons' introduction
05:00Maja Pirnat, Maribor / SI, Alexandros Kallifatidis, Thessaloniki / GR
2
Epidemiology, diagnosis, and therapy of amyloidosis: the clinical perspective
15:00Efstathios Kastritis, Athens / GR
3
The role of magnetic resonance in the diagnosis of cardiac amyloidosis
15:00Jean-Nicolas Dacher, Rouen / FR
4
The role of nuclear medicine in amyloidosis
15:00Simona Ben-Haim, Jerusalem / IL
5
Panel discussion: The imaging algorithm for cardiac amyloidosis: what, when and why
10:00Panel discussion: The imaging algorithm for cardiac amyloidosis: what, when and why
5 min
Chairpersons' introduction
Maja Pirnat, Maribor / Slovenia
Alexandros Kallifatidis, Thessaloniki / Greece
Alexandros Kallifatidis, Thessaloniki / Greece
15 min
Epidemiology, diagnosis, and therapy of amyloidosis: the clinical perspective
Efstathios Kastritis, Athens / Greece
- To describe the systemic amyloidosis disease spectrum.
- To summarise the treatment approaches in amyloidosis.
- To discuss the challenges in diagnosis and patient management.
15 min
The role of magnetic resonance in the diagnosis of cardiac amyloidosis
Jean-Nicolas Dacher, Rouen / France
- To describe the major cardiac magnetic resonance anomalies encountered in patients with cardiac amyloidosis.
- To distinguish between the two main types of cardiac amyloidosis (amyloid light chain [AL] and transthyretin [ATTR]).
- To understand the role of cardiac MR in the follow-up of patients.
15 min
The role of nuclear medicine in amyloidosis
Simona Ben-Haim, Jerusalem / Israel
- To describe which radiopharmaceuticals are used for ATTR cardiac amyloidosis.
- To examine and grade bone-avid tracer scans.
- To differentiate ATTR from AL in suspected cardiac amyloidosis.
10 min
Panel discussion: The imaging algorithm for cardiac amyloidosis: what, when and why